A vaccine against Covid-19 is urgently needed if we’re to stop the novel coronavirus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal.

We have published early results (https://www.ovg.ox.ac.uk/news/new-study-reveals-oxford-coronavirus-vaccine-produces-strong-immune-response) from our clinical trial of the vaccine ChAdOx1 nCoV-19 (also known as AZD1222), designed by the University of Oxford and developed in partnership with AstraZeneca. The preliminary data shows that it is safe and induced a strong antibody response in all vaccinated volunteers, suggesting that an effective vaccine could be within reach...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now